Flow cytometric assay for determination of FcγRIIIA-158 V/F polymorphism

Journal of Immunological Methods

Volumn 306, Issue 1-2, 2005, Pages 128-136

  Böttcher, Sebastian ^a   Ritgen, Matthias ^a   Brüggemann, Monika ^a   Raff, Thorsten ^a   Lüschen, Silke ^a   Humpe, Andreas ^a   Kneba, Michael ^a   Pott, Christiane ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

FCGR3A; Flow cytometry; Methods; Polymorphism

Indexed keywords

AMINO ACID; CD16 ANTIGEN; FC GAMMA RECEPTOR IIIA 158; FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; MONOCLONAL ANTIBODY; PHENYLALANINE; UNCLASSIFIED DRUG; VALINE;

ADULT; ALLELE; ALLOTYPE; ANTIBODY DETECTION; ARTICLE; DNA POLYMORPHISM; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; IMMUNOFLUORESCENCE; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTIBODIES, MONOCLONAL; EPITOPES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENOTYPE; HUMANS; KILLER CELLS, NATURAL; PHENYLALANINE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; VALINE;

EID: 28444459587     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.08.004     Document Type: Article

References (26)

1. J.H. Anolik, D. Campbell, R.E. Felgar, F. Young, I. Sanz, J. Rosenblatt, and R.J. Looney The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus Arthritis Rheum. 48 2003 455
2. M.D. Carcao, V.S. Blanchette, C.D. Wakefield, D. Stephens, J. Ellis, K. Matheson, and G.A. Denomme Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura Br. J. Haematol. 120 2003 135
3. G. Cartron, L. Dacheux, G. Salles, P. Solal Celigny, P. Bardos, P. Colombat, and H. Watier Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene Blood 99 2002 754
4. S. Dall'Ozzo, C. Andres, P. Bardos, H. Watier, and G. Thibault Rapid single-step FCGR3A genotyping based on SYBR Green I fluorescence in real-time multiplex allele-specific PCR J. Immunol. Methods 277 2003 185
5. S. Dall'Ozzo, S. Tartas, G. Paintaud, G. Cartron, P. Colombat, P. Bardos, H. Watier, and G. Thibault Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship Cancer Res. 64 2004 4664
6. J.C. Edberg, and R.P. Kimberly Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding J. Immunol. 159 1997 3849
7. J.C. Edberg, C.D. Langefeld, J. Wu, K.L. Moser, K.M. Kaufman, J. Kelly, V. Bansal, W.M. Brown, J.E. Salmon, S.S. Rich, J.B. Harley, and R.P. Kimberly Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus Arthritis Rheum. 46 2002 2132
8. J.E. Gessner, H. Heiken, A. Tamm, and R.E. Schmidt The IgG Fc receptor family Ann. Hematol. 76 1998 231
9. B. Huard, L. Karlsson, and F. Triebel KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation Eur. J. Immunol. 31 2001 1728
10. H.R. Koene, M. Kleijer, J. Algra, D. Roos, A.E. dem Borne, and M. de Haas Fc gammaRIIIa-158 V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype Blood 90 1997 1109
11. T. Lehrnbecher, C.B. Foster, S. Zhu, S.F. Leitman, L.R. Goldin, K. Huppi, and S.J. Chanock Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations Blood 94 1999 4220
12. F.G. Leppers-van de Straat, W.L. van der Pol, M.D. Jansen, N. Sugita, H. Yoshie, T. Kobayashi, and J.G. Van De Winkel A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping J. Immunol. Methods 242 2000 127
13. E. Louis, Z. El Ghoul, S. Vermeire, S. Dall'Ozzo, P. Rutgeerts, G. Paintaud, J. Belaiche, M. De Vos, A. Van Gossum, J.F. Colombel, and H. Watier Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease Aliment. Pharmacol. Ther. 19 2004 511
14. M.J. Loza, and B. Perussia The IL-12 signature: NK cell terminal CD56+ high stage and effector functions J. Immunol. 172 2004 88
15. A.W. Morgan, V.H. Keyte, S.J. Babbage, J.I. Robinson, F. Ponchel, J.H. Barrett, B.B. Bhakta, S.J. Bingham, M.H. Buch, P.G. Conaghan, A. Gough, M. Green, C.A. Lawson, C.T. Pease, A.F. Markham, W.E. Ollier, P. Emery, J. Worthington, and J.D. Isaacs FcgammaRIIIA-158 V and rheumatoid arthritis: a confirmation study Rheumatology (Oxf.) 42 2003 528
16. R. Niwa, S. Hatanaka, E. Shoji-Hosaka, M. Sakurada, Y. Kobayashi, A. Uehara, H. Yokoi, K. Nakamura, and K. Shitara Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism Clin. Cancer Res. 10 2004 6248
17. J.V. Ravetch, and B. Perussia Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions J. Exp. Med. 170 1989 481
18. R.L. Shields, A.K. Namenuk, K. Hong, Y.G. Meng, J. Rae, J. Briggs, D. Xie, J. Lai, A. Stadlen, B. Li, J.A. Fox, and L.G. Presta High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R J. Biol. Chem. 276 2001 6591
19. R.L. Shields, J. Lai, R. Keck, L.Y. O'Connell, K. Hong, Y.G. Meng, S.H. Weikert, and L.G. Presta Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity J. Biol. Chem. 277 2002 26733
20. K.E. Sullivan, A.F. Jawad, L.M. Piliero, N. Kim, X. Luan, D. Goldman, and M. Petri Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus Rheumatology (Oxf.) 42 2003 446
21. A. Tamm, and R.E. Schmidt The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding J. Immunol. 157 1996 1576
22. A. Tamm, A. Kister, K.U. Nolte, J.E. Gessner, and R.E. Schmidt The IgG binding site of human FcgammaRIIIB receptor involves CC' and FG loops of the membrane-proximal domain J. Biol. Chem. 271 1996 3659
23. S.P. Treon, M. Hansen, A.R. Branagan, S. Verselis, C. Emmanouilides, E. Kimby, S.R. Frankel, N. Touroutoglou, B. Turnbull, K.C. Anderson, D.G. Maloney, and E.A. Fox Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenstrom's macroglobulinemia J. Clin. Oncol. 23 2005 474
24. W.L. van der Pol, M.D. Jansen, W.J. Sluiter, S.B. van de, F.G. Leppers-van de Straat, T. Kobayashi, R.G. Westendorp, T.W. Huizinga, and J.G. Van De Winkel Evidence for non-random distribution of Fcgamma receptor genotype combinations Immunogenetics 55 2003 240
25. W.K. Weng, and R. Levy Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma J. Clin. Oncol. 21 2003 3940
26. J. Wu, J.C. Edberg, P.B. Redecha, V. Bansal, P.M. Guyre, K. Coleman, J.E. Salmon, and R.P. Kimberly A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease J. Clin. Invest. 100 1997 1059